These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10635398)

  • 21. Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck.
    Overgaard J; Alsner J; Eriksen J; Horsman MR; Grau C
    Rays; 2000; 25(3):313-9. PubMed ID: 11367896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in radiotherapy for carcinoma of the head and neck.
    Morris MM; Schmidt-Ullrich R; Johnson CR
    Surg Oncol Clin N Am; 2000 Jul; 9(3):563-75, x. PubMed ID: 10853142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy for head and neck cancer: latest developments and future perspectives.
    Bernier J; Bentzen SM
    Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of various fractionation schedule in curative radiotherapy alone of locally advanced head and neck tumors].
    Baumann M; Klages HT
    Strahlenther Onkol; 2001 Mar; 177(3):162-5. PubMed ID: 11285776
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of dose and volume on radiation-induced mucositis.
    Mantini G; Manfrida S; Cellini F; Giammarino D; Petrone A; Vitucci P; Cellini N
    Rays; 2005; 30(2):137-44. PubMed ID: 16294906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thoracic radiotherapy for limited-stage small cell lung cancer: issues of timing, volumes, dose, and fractionation.
    Erridge SC; Murray N
    Semin Oncol; 2003 Feb; 30(1):26-37. PubMed ID: 12635087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperfractionated accelerated radiotherapy alone and with concomitant chemotherapy to the head and neck: treated within and outside of randomized clinical trials.
    Hehr T; Classen J; Schreck U; Glocker S; Bamberg M; Budach W
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1424-30. PubMed ID: 15050319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Planning in the IGRT context: closing the loop.
    Mageras GS; Mechalakos J
    Semin Radiat Oncol; 2007 Oct; 17(4):268-77. PubMed ID: 17903704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
    Skladowski K; Maciejewski B; Golen M; Tarnawski R; Slosarek K; Suwinski R; Sygula M; Wygoda A
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):706-13. PubMed ID: 17011446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
    Chen AM; Vaughan A; Narayan S; Vijayakumar S
    Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series.
    Welz H; Pöttgen C; Abu Jawad J; Wierlemann A; Wittig A; Stüben G; Budach V; Lehnerdt G; Jahnke K; Sack H; Stuschke M
    Oncology; 2009; 76(6):405-12. PubMed ID: 19407473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperfractionation: where do we stand?
    Stuschke M; Thames H
    Radiother Oncol; 1998 Feb; 46(2):131-3. PubMed ID: 9510040
    [No Abstract]   [Full Text] [Related]  

  • 36. Accelerated fractionation: the do's and don'ts--regarding Fu et al., Bourhis et al. and Delaney et al., IJROBP 32:589-597; 1995.
    Wang CC
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):889-90. PubMed ID: 7790278
    [No Abstract]   [Full Text] [Related]  

  • 37. CHART (continuous, hyperfractionated, accelerated radiotherapy): a tale of two disciplines.
    Saunders MI; Dische S; Rojas A
    Br J Cancer; 1999 Jul; 80 Suppl 1():110-5. PubMed ID: 10466769
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcome of hyperfractionated radiation therapy in randomized clinical trials.
    Willers H; Liertz-Petersen C; Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):257-9. PubMed ID: 9422584
    [No Abstract]   [Full Text] [Related]  

  • 39. Altered fractionation schedules in radiotherapy of head and neck cancer. A review.
    Fallai C; Olmi P
    Tumori; 1992 Oct; 78(5):311-25. PubMed ID: 1494804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy with thrice-a-day-fractionation in a short overall time.
    van den Bogaert W; van der Schueren E
    Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1133-4. PubMed ID: 7298406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.